Active Ingredient History
Ribavirin elaidate (CP-4033; TRX-201), a Lipid Vector Technology derivative of ribavirin. It inhibits elongation factor F4E (elF4E), which stimulates cell growth. Translational Therapeutics Inc. received orphan drug status from the U.S. Food and Drug Administration (FDA) in 2011 for ribavirin elaidate in the treatment of aggressive follicular, medullary and anaplastic thyroid carcinoma. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acute-On-Chronic Liver Failure (Phase 4)
Alcoholism (Phase 4)
Amputation, Surgical (Phase 4)
Anemia (Phase 4)
Anemia, Hemolytic (Phase 3)
Antiviral Agents (Phase 4)
Asian (Phase 4)
Astigmatism (Phase 1/Phase 2)
Bone Marrow Transplantation (Phase 2)
Breast Neoplasms (Phase 1/Phase 2)
Carcinoma, Hepatocellular (Phase 4)
Chronic Disease (Phase 4)
Chronic Pain (Phase 2)
Coinfection (Phase 3)
Common Cold (Phase 4)
Corneal Diseases (Phase 3)
COVID-19 (Phase 3)
Dengue (Phase 2)
Depression (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 2)
Diabetes Mellitus, Type 2 (Phase 4)
Digestive System Diseases (Phase 2)
Dilatation, Pathologic (Phase 3)
Drug Misuse (Phase 4)
Encephalitis, Japanese (Phase 2)
Endoscopy (Phase 2/Phase 3)
Enterovirus (Phase 2)
Fatty Liver (Phase 4)
Fever (Phase 2)
Fibrosis (Phase 4)
Flaviviridae Infections (Phase 2)
Genotype (Phase 4)
Hand, Foot and Mouth Disease (Phase 4)
Healthy Volunteers (Phase 1)
Heart Transplantation (Phase 4)
Hematologic Neoplasms (Phase 4)
Hemoglobinopathies (Phase 4)
Hemophilia A (Phase 4)
Hemorrhagic Disorders (Phase 2)
Hemorrhagic Fever, Crimean (Phase 2)
Hemorrhagic Fever with Renal Syndrome (Phase 2)
Hepacivirus (Phase 4)
Hepatic Insufficiency (Phase 1)
Hepatitis (Phase 4)
Hepatitis B (Phase 3)
Hepatitis B, Chronic (Phase 4)
Hepatitis C (Phase 4)
Hepatitis, Chronic (Phase 3)
Hepatitis D, Chronic (Phase 4)
Hepatitis E (Phase 4)
Hepatitis, Viral, Human (Phase 2)
Herpangina (Phase 4)
HIV (Phase 4)
HIV Infections (Phase 4)
Hyperopia (Phase 1/Phase 2)
Hypertension, Portal (Phase 2)
Infections (Phase 3)
Infertility, Male (Phase 2/Phase 3)
Influenza A virus (Phase 3)
Influenza, Human (Phase 4)
Insulin Resistance (Phase 4)
Keratoconus (Phase 3)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 4)
Kidney Transplantation (Phase 4)
Lassa Fever (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Ligaments (Early Phase 1)
Liver (Phase 2)
Liver Cirrhosis, Experimental (Phase 2/Phase 3)
Liver Diseases (Phase 4)
Liver Failure (Phase 2)
Liver Transplantation (Phase 4)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Early Phase 1)
Lymphoma, Mantle-Cell (Early Phase 1)
Menopause (Phase 3)
Neoplasms (Phase 4)
Opioid-Related Disorders (Phase 3)
Osteomyelitis (Phase 4)
Pharmacokinetics (Phase 3)
Pharmacology (Phase 2/Phase 3)
Pneumonia (Phase 2)
Recurrence (Phase 3)
Renal Dialysis (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Respiratory Syncytial Virus Infections (Phase 3)
Respiratory Tract Infections (Phase 4)
RNA Virus Infections (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Substance-Related Disorders (Phase 4)
Thalassemia (Phase 4)
Therapeutics (Phase 4)
Therapeutic Uses (Phase 4)
Thrombocytopenia (Phase 2)
Treatment Failure (Phase 2)
Virus Diseases (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue